Specialized Medical Company Profit Margin

The latest profit margin for 4019.SR is 17.69% as of June 2026. That compares with 10.29% in the prior-year period — up 71.9% year over year. That is above the sector sector average of 13.23%. Investors often review this figure alongside Specialized Medical Company's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4019.SR's profit margin moved from 10.29% to 17.69% — a 71.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Specialized Medical Company's valuation or profitability profile.

Against its sector companies, 4019.SR currently prints 17.69% for profit margin, while the sector average sits near 13.23%. That is roughly 33.7% above the sector mean. Large gaps often invite a closer look at Specialized Medical Company's growth, margins, and balance sheet.

Profit Margin shows how effectively Specialized Medical Company converts resources into returns. At 17.69%, 4019.SR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 10.29% in the prior-year period — up 71.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 4019.SR's profit margin (17.69%), review year-over-year change from 10.29%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.